Page last updated: 2024-11-04

vorinostat and Parasite Infections

vorinostat has been researched along with Parasite Infections in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
"Vorinostat is a drug used to treat cutaneous T cell lymphoma whose action mechanism is based on Histone Deacetylase inhibition."2.66Vorinostat as potential antiparasitic drug. ( Ariza-Ortega, JA; Flores-García, Y; Herrera-Martínez, M; López-Contreras, L; Montaño, S; Orozco-Samperio, E, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Herrera-Martínez, M1
Orozco-Samperio, E1
Montaño, S1
Ariza-Ortega, JA1
Flores-García, Y1
López-Contreras, L1

Reviews

1 review available for vorinostat and Parasite Infections

ArticleYear
Vorinostat as potential antiparasitic drug.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:13

    Topics: Animals; Antiparasitic Agents; Drug Repositioning; Histone Deacetylase Inhibitors; Histone Deacetyla

2020